Optimal strategies to improve uptake of and adherence to HIV prevention among young people at risk for HIV acquisition in the USA (ATN 149): a randomised, controlled, factorial trial. The Lancet.

Swendeman, D., Rotheram-Borus, M. J., Arnold, E. M., Fernández, M. I., Comulada, W. S., Lee, S. J., Ocasio, M. A., Ishimoto, K., Gertsch, W., Duan, N., Reback, C. J., Murphy, D. A., Lewis, K. A., & Adolescent HIV Medicine Trials Network (ATN) CARES Study Team (2024). Optimal strategies to improve uptake of and adherence to HIV prevention among young people at risk for HIV acquisition in the USA (ATN 149): a randomised, controlled, factorial trial. The Lancet. The Lancet. Digital health, 6(3), e187–e200. https://doi.org/10.1016/S2589-7500(23)00252-2.